Clinical Trial Update: Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating dual-target CAR-NK cells designed to treat HER2-positive and triple-negative breast cancers, with the study currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Dual-Target CAR-NK Cells

Snippet

Sponsor: Beijing Biotech | Conditions: Breast Cancer (Locally Advanced or Metastatic), HER2-positive Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING